BillionToOne Beats the Odds With $15 Million Series A

BillionToOne says it has closed a highly oversubscribed Series A funding round of $15 million. Hummingbird Ventures and NeoTribe Ventures led the investment round with participation from Y Combinator, Civilization Ventures, Fifty Years, 500 Startups Istanbul, and HOF Capital.

BillionToOne is a precision diagnostics company and inventors of the patent-pending molecular counter platform, which increases the resolution of cell-free DNA detection by over a thousandfold.

The funding will be used to support growth and the launch of BillionToOne’s first product—UNITY, a non-invasive prenatal test for recessively inherited single gene disorders.

Read more at Silicon Valley Daily